Literature DB >> 29056429

Three-Dimensional Microbiome and Metabolome Cartography of a Diseased Human Lung.

Neha Garg1, Mingxun Wang2, Embriette Hyde3, Ricardo R da Silva1, Alexey V Melnik1, Ivan Protsyuk4, Amina Bouslimani1, Yan Wei Lim5, Richard Wong6, Greg Humphrey3, Gail Ackermann3, Timothy Spivey7, Sharon S Brouha7, Nuno Bandeira2, Grace Y Lin6, Forest Rohwer5, Douglas J Conrad8, Theodore Alexandrov9, Rob Knight10, Pieter C Dorrestein11.   

Abstract

Our understanding of the spatial variation in the chemical and microbial makeup of an entire human organ remains limited, in part due to the size and heterogeneity of human organs and the complexity of the associated metabolome and microbiome. To address this challenge, we developed a workflow to enable the cartography of metabolomic and microbiome data onto a three-dimensional (3D) organ reconstruction built off radiological images. This enabled the direct visualization of the microbial and chemical makeup of a human lung from a cystic fibrosis patient. We detected host-derived molecules, microbial metabolites, medications, and region-specific metabolism of medications and placed it in the context of microbial distributions in the lung. Our tool further created browsable maps of a 3D microbiome/metabolome reconstruction map on a radiological image of a human lung and forms an interactive resource for the scientific community.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cartography; cystic fibrosis; mass spectrometry; metabolomics; microbiome; molecular networking

Mesh:

Substances:

Year:  2017        PMID: 29056429      PMCID: PMC6267898          DOI: 10.1016/j.chom.2017.10.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  37 in total

1.  Mass spectral molecular networking of living microbial colonies.

Authors:  Jeramie Watrous; Patrick Roach; Theodore Alexandrov; Brandi S Heath; Jane Y Yang; Roland D Kersten; Menno van der Voort; Kit Pogliano; Harald Gross; Jos M Raaijmakers; Bradley S Moore; Julia Laskin; Nuno Bandeira; Pieter C Dorrestein
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

Review 3.  HUMAN MICROBIOTA. Small molecules from the human microbiota.

Authors:  Mohamed S Donia; Michael A Fischbach
Journal:  Science       Date:  2015-07-23       Impact factor: 47.728

4.  Quantitative analysis of regional airways obstruction using dynamic hyperpolarized 3He MRI-preliminary results in children with cystic fibrosis.

Authors:  Panos Koumellis; Edwin J R van Beek; Neil Woodhouse; Stan Fichele; Andrew J Swift; Martyn N J Paley; Catherine Hill; Chris J Taylor; Jim M Wild
Journal:  J Magn Reson Imaging       Date:  2005-09       Impact factor: 4.813

Review 5.  Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.

Authors:  S P Conway; K G Brownlee; M Denton; D G Peckham
Journal:  Am J Respir Med       Date:  2003

6.  Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections.

Authors:  Cara N Wilder; Gopal Allada; Martin Schuster
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

7.  Biogeography and individuality shape function in the human skin metagenome.

Authors:  Julia Oh; Allyson L Byrd; Clay Deming; Sean Conlan; Heidi H Kong; Julia A Segre
Journal:  Nature       Date:  2014-10-02       Impact factor: 49.962

8.  Global and local selection acting on the pathogen Stenotrophomonas maltophilia in the human lung.

Authors:  Hattie Chung; Tami D Lieberman; Sara O Vargas; Kelly B Flett; Alexander J McAdam; Gregory P Priebe; Roy Kishony
Journal:  Nat Commun       Date:  2017-01-19       Impact factor: 14.919

9.  Advancing our understanding of the human microbiome using QIIME.

Authors:  José A Navas-Molina; Juan M Peralta-Sánchez; Antonio González; Paul J McMurdie; Yoshiki Vázquez-Baeza; Zhenjiang Xu; Luke K Ursell; Christian Lauber; Hongwei Zhou; Se Jin Song; James Huntley; Gail L Ackermann; Donna Berg-Lyons; Susan Holmes; J Gregory Caporaso; Rob Knight
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

10.  Tumour-associated and non-tumour-associated microbiota in colorectal cancer.

Authors:  Burkhardt Flemer; Denise B Lynch; Jillian M R Brown; Ian B Jeffery; Feargal J Ryan; Marcus J Claesson; Micheal O'Riordain; Fergus Shanahan; Paul W O'Toole
Journal:  Gut       Date:  2016-03-18       Impact factor: 23.059

View more
  49 in total

Review 1.  Cross-species RNA-seq for deciphering host-microbe interactions.

Authors:  Alexander J Westermann; Jörg Vogel
Journal:  Nat Rev Genet       Date:  2021-02-17       Impact factor: 53.242

2.  The chemical topology of a bacterial swarm.

Authors:  Neha Garg; Marvin Whiteley
Journal:  J Biol Chem       Date:  2018-06-15       Impact factor: 5.157

Review 3.  Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.

Authors:  Roberto Mendez; Sulagna Banerjee; Sanjoy K Bhattacharya; Santanu Banerjee
Journal:  IUBMB Life       Date:  2018-11-22       Impact factor: 3.885

4.  Achromobacter xylosoxidans Cellular Pathology Is Correlated with Activation of a Type III Secretion System.

Authors:  Adam M Pickrum; Orlando DeLeon; Aaron Dirck; Maxx H Tessmer; Molly O Riegert; Julie A Biller; Nathan A Ledeboer; John R Kirby; Dara W Frank
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 5.  Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes.

Authors:  Kathy N Lam; Margaret Alexander; Peter J Turnbaugh
Journal:  Cell Host Microbe       Date:  2019-07-10       Impact factor: 21.023

Review 6.  Methods in Lung Microbiome Research.

Authors:  Sharon M Carney; Jose C Clemente; Michael J Cox; Robert P Dickson; Yvonne J Huang; Georgios D Kitsios; Kirsten M Kloepfer; Janice M Leung; Tricia D LeVan; Philip L Molyneaux; Bethany B Moore; David N O'Dwyer; Leopoldo N Segal; Stavros Garantziotis
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

7.  Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  J Cyst Fibros       Date:  2019-04-26       Impact factor: 5.482

Review 8.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

9.  Spatial Metabolomics and Imaging Mass Spectrometry in the Age of Artificial Intelligence.

Authors:  Theodore Alexandrov
Journal:  Annu Rev Biomed Data Sci       Date:  2020-04-13

10.  Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis.

Authors:  B T Kopp; E Joseloff; D Goetz; B Ingram; S L Heltshe; D H Leung; B W Ramsey; K McCoy; D Borowitz
Journal:  J Cyst Fibros       Date:  2018-11-23       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.